Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.

Cancer genomics & proteomics - 1 Jan 2000

Pectasides Eirini, Chatzidakis Ioannis, Kotoula Vassiliki, Koliou Georgia-Angeliki, Papadopoulou Kyriaki, Giannoulatou Eleni, Giannouzakos Vasilios G, Bobos Mattheos, Papavasileiou Christos, Chrisafi Sofia, Florou Aikaterini, Pectasides Dimitrios, Fountzilas George

Abstract excerpt

BACKGROUND/AIM: Early-stage gastric cancer has a high risk of recurrence, despite trimodality therapy with surgery, chemotherapy and radiation. To improve patient selection for adjuvant chemoradiotherapy, we evaluated the prognostic significance of immunohistochemical and genetic biomarkers in patients with resected gastric adenocarcinoma. PATIENTS AND METHODS: Tumors from 119 patients were subjected to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Neoplasm Staging

Share to Proto-Oncogene Proteins p21(ras)

Share to PTEN Phosphohydrolase

Share to Stomach Neoplasms

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 32345669
DOI: 10.21873/cgp.20188
PMCID: PMC7259883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy.PMID 32345669Read ↗

Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic ImplicationsSemantic proximity Read ↗

Gastric biomarkers: a global reviewSemantic proximity Read ↗

Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosisSemantic proximity Read ↗

Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancerSemantic proximity Read ↗

Immunohistochemistry-based molecular classification using TCGA and ACRG Algorithm in locally advanced and metastatic gastric cancerSemantic proximity Read ↗

Molecular Diagnosis for Personalized Target Therapy in Gastric CancerSemantic proximity Read ↗

Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancerSemantic proximity Read ↗

Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.Semantic proximity Read ↗

Molecular Prognostic Factors in Adenocarcinoma of the Esophagus and Gastroesophageal JunctionSemantic proximity Read ↗

Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer.Semantic proximity Read ↗

Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review)Semantic proximity Read ↗

PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.